This philanthropically-funded project is led by Dr David Miller – Boston Children’s Hospital, Harvard. Adrienne Flanagan and Nischalan Pillay and the RNOH pathologists are major contributors to the study which involves an in-depth integrated genetic, transcriptomic and epigenetic data analyses from these neoplasms in order to understand the basic biology of this disease with the aim of identifying prognostic and therapeutic markers.
Was this page helpful? Let us know